Salix Pharmaceuticals Aktie

Salix Pharmaceuticals für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 984339 / ISIN: US7954351067

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
03.10.2014 19:37:00

Salix Pharmaceuticals, Ltd. -- Moody's: Salix's termination of Cosmo merger removes a credit positive

New York, October 03, 2014 -- Moody's Investors Service commented that the termination of the merger agreement between Salix Pharmaceuticals, Ltd. ("Salix") and Cosmo Technologies Limited ("Cosmo Tech") eliminates a credit positive benefit for Salix. There is no impact on Salix's ratings including the B1 Corporate Family Rating, or the stable rating outlook.

Vollständigen Artikel bei Moodys lesen